1-4 of 4
Yi Qian
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Significant Contribution of Pain in Determining the Health Status of Patients with Multiple Myeloma (MM)

Tito R. Mendoza, PhD, Amylou C. Dueck, PhD, Qiuling Shi, PhD, Haijun Ma, PhD, Jeffrey Zhang, PhD, Yi Qian, PhD, Charles S. Cleeland, PhD
Journal: Blood
Blood (2015) 126 (23): 4495.
https://doi.org/10.1182/blood.V126.23.4495.4495
Published: 2015
Journal Articles

Utilization Patterns of Bone-Targeting Agents Among Patients with Multiple Myeloma: Analysis of Real-World Data

Yi Qian, PhD, Debajyoti Bhowmik, B.Pharm, PhD, Nandita Kachru, MS, Rohini K. Hernandez, PhD, Paul Cheng, MD PhD, Alexander Liede, BSc, MSc, PhD
Journal: Blood
Blood (2015) 126 (23): 4501.
https://doi.org/10.1182/blood.V126.23.4501.4501
Published: 2015
Journal Articles

Pain and Health-Related Quality of Life (HRQoL) in Patients with Relapsed and Plateau-Phase (PP) Multiple Myeloma (MM) Treated with Denosumab

Karen C Chung, PharmD, MS, Arie Barlev, PharmD, MS, Yi Qian, PhD, Susie Jun, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2388.
https://doi.org/10.1182/blood.V112.11.2388.2388
Published: 2008
Journal Articles

An Open-Label, Phase 2 Trial of Denosumab in the Treatment of Relapsed (R) or Plateau-Phase (PP) Multiple Myeloma (MM).

Ravi Vij, Noemi Horvath, Andrew Spencer, Kerry Taylor, Saroj Vadhan-Raj, Judy Smith, Yi Qian, Susie Jun
Journal: Blood
Blood (2007) 110 (11): 3604.
https://doi.org/10.1182/blood.V110.11.3604.3604
Published: 2007